Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Timothy J Hobday

Showing results (1-10 of 71) with videos related to

Pageof 8
Sort By:
Clinical Colorectal Cancer|May 6, 2005
An overview of approaches to adjuvant therapy for colorectal cancer in the United StatesTimothy J Hobday
Clinical Colorectal Cancer|November 27, 2002
Adjuvant therapy of colon cancer: a reviewTimothy J Hobday, Charles Erlichman
Clinical Colorectal Cancer|December 17, 2002
Perspectives on the role of sequential or combination chemotherapy for first-line and salvage therapy in advanced colorectal cancerTimothy J Hobday, Richard M Goldberg
Cancer Control : Journal of the Moffitt Cancer Center|April 28, 2005
Molecularly targeted therapies for breast cancerTimothy J Hobday, Edith A Perez
International Journal of Hepatology|December 11, 2012
Treatment of neuroendocrine tumor liver metastasesMark A Lewis, Timothy J Hobday
Mayo Clinic Proceedings|December 10, 2003
Imatinib mesylate-induced interstitial pneumonitisCynthia X Ma, Timothy J Hobday, James R Jett
The American Journal of Gastroenterology|November 22, 2007
Medical management of pancreatic neuroendocrine tumorsThierry Delaunoit, Florence Neczyporenko, Joseph Rubin, et al.
Mayo Clinic Proceedings|April 12, 2005
Somatostatin analogues in the treatment of gastroenteropancreatic neuroendocrine tumorsThierry Delaunoit, Joseph Rubin, Florence Neczyporenko, et al.
Therapeutics and Clinical Risk Management|April 2, 2009
Colorectal cancer patients with liver metastases and severe hyperbilirubinemia: A consecutive series that explores the benefits and risks of chemotherapyTamana Walia, J Fernando Quevedo, Timothy J Hobday, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]|April 26, 2021
Intratumoral Interleukin-2 Injections Without Systemic Therapy for Isolated Cutaneous Metastatic Breast CancerBenjamin G Gorman, James W Jakub, Timothy J Hobday, et al.
Pageof 8

Showing results (1-10 of 71) with videos related to

Sort By:
Pageof 8
Clinical Colorectal Cancer|May 6, 2005
An overview of approaches to adjuvant therapy for colorectal cancer in the United StatesTimothy J Hobday
Clinical Colorectal Cancer|November 27, 2002
Adjuvant therapy of colon cancer: a reviewTimothy J Hobday, Charles Erlichman
Clinical Colorectal Cancer|December 17, 2002
Perspectives on the role of sequential or combination chemotherapy for first-line and salvage therapy in advanced colorectal cancerTimothy J Hobday, Richard M Goldberg
Cancer Control : Journal of the Moffitt Cancer Center|April 28, 2005
Molecularly targeted therapies for breast cancerTimothy J Hobday, Edith A Perez
International Journal of Hepatology|December 11, 2012
Treatment of neuroendocrine tumor liver metastasesMark A Lewis, Timothy J Hobday
Mayo Clinic Proceedings|December 10, 2003
Imatinib mesylate-induced interstitial pneumonitisCynthia X Ma, Timothy J Hobday, James R Jett
The American Journal of Gastroenterology|November 22, 2007
Medical management of pancreatic neuroendocrine tumorsThierry Delaunoit, Florence Neczyporenko, Joseph Rubin, et al.
Mayo Clinic Proceedings|April 12, 2005
Somatostatin analogues in the treatment of gastroenteropancreatic neuroendocrine tumorsThierry Delaunoit, Joseph Rubin, Florence Neczyporenko, et al.
Therapeutics and Clinical Risk Management|April 2, 2009
Colorectal cancer patients with liver metastases and severe hyperbilirubinemia: A consecutive series that explores the benefits and risks of chemotherapyTamana Walia, J Fernando Quevedo, Timothy J Hobday, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]|April 26, 2021
Intratumoral Interleukin-2 Injections Without Systemic Therapy for Isolated Cutaneous Metastatic Breast CancerBenjamin G Gorman, James W Jakub, Timothy J Hobday, et al.
Pageof 8